1. Acheson ED. Epidemiology of multiple sclerosis. Br Med Bull 1977; 33:9-14.

2. Kurtzke JF, Beebe GW, Norman JE. Epidemiology of multiple sclerosis in US veterans. 1. Race, sex, and geographical distribution. Neurology 1979; 29(9 Pt 1):1228-1235.

3. Charcot JM. Lectures on the disease of the nervous system. In: Vol 1. London: The New Sydenham Society, 1877:157-222.

4. Schumacher GA, Beebe G, Kubler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965; 122:522-568.

5. Miller DH. Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol 1994; 36(suppl):S91-S94.

6. Yahr MD, Goldensohn SS, Kabat EA. Further studies on the gamma globulin content of cerebrospinal fluid in multiple sclerosis and other neurological diseases. Ann NY Acad Sci 1954; 58:613-624.

7. Lumsden CE. The proteins of cerebrospinal fluid (continued). In: McAlpine D, Lumsden CE, Acheson ED, eds. Multiple Sclerosis: A Re-appraisal. Edinburgh: Churchill Livingstone, 1972:543-548.

8. Olsson JE, Peterson B. A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological disease. Acta Neurol Scand 1976; 53: 308-322.

9. Tourtellotte WW, Ma BI. Multiple sclerosis: the blood-brain barrier and measurement of de novo central system IgG synthesis. Neurology 1978; 28:76-83.

10. Link H, Muller R. Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol 1971; 25:326-344.

11. Schmidt RM, Neumann V. CSF-oligoclonal bands in multiple sclerosis. In: Bauer HJ, Poser S, Ritter G, eds. Progress in Multiple Sclerosis Research. Berlin: Springer-Verlag, 1980:123-128.

12. Kostulas VK, Link H. Agarose isoelectric focusing of unconcentrated CSF and radio-immunofixation for detection of oligoclonal bands in patients with multiple sclerosis and other neurological diseases. J Neurol Sci 1982; 54:117-127.

13. Ebers GC, Paty DW. CSF electrophoresis in one thousand patients. Can J Neurol Sci 1980; 7:275-280.

14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-231.

15. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-127.

16. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.

17. Tintore M, Rovira A, Brieva L, et al. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler 2001; 7:359-363.

18. Paty DW, Oger JJF, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38:180-185.

Offenbacher H, Fazekas F, Schmidt R, et al. Assessment of MRI criteria for a diagnosis of MS. Neurology 1993; 43:905-909.

Thompson PPMS, Thompson AJ, Montalban X, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47:831-835. Frohman EM, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2003; 61:602-611.

Dalton CM, Brex PA, Miskiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002; 52:47-53.

Tintore M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003; 60:27-30.

Giroud M, Semama D, Pradrans L, Gouyon JB, Dumas R, Nivelon JL. Hemiballismus revealing multiple sclerosis in an infant. Childs Nerv Syst 1990; 6:236-238. Brandt S, Gyldensted C, Offner H, Melchior JC. Multiple sclerosis with onset in a two-year old boy. Neuropediatrics 1981; 12:75-82.

Hauser SL, Bresman MJ, Reinherz EL, Weiner HL. Childhood multiple sclerosis: clinical features and demonstration of changes in T cell subsets with disease activity. Ann Neurol 1982; 11:463-468.

Muller R. Course and prognosis of disseminated sclerosis in relation to age of onset. Arch Neurol Psychiatry 1951; 66:561-570.

Allison RS, Millar JHD. Prevalence and familiar incidence of disseminated sclerosis in Northern Island. Ulster Med 1954; 23(2):l-92.

Poskanzer DC, Schapira K, Miller H. Epidemiology of multiple sclerosis in the counties of Northumberland and Durham. J Neurol Neurosurg Psychiatry 1963; 26:368-376. Duquette P, Murray TJ, Pleines J, et al. Multple sclerosis in childhood: clinical profile in 125 patients. J Pediatr 1987; 111:359-363.

Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G. Multiple sclerosis after age 50. Neurology 1983; 33:37-44.

Cazzulo GL, Ghezzi A, Marforio S, Caputo D. Clinical picture of multiple sclerosis with late onset. Acta Neurol Scand 1978; 58:190-196.

Leibowitz U, Alter M, Halper L. Clinical studies of multiple sclerosis in Israel. III. Clinical course and prognosis related to age. Neurology 1964; 14:926-932. Shepherd DI. Clinical features of multiple sclerosis in north-east Scotland. Acta Neurol Scand 1979; 60:218-230.

Friedman AP, Davison C. Multiple sclerosis with late onset of symptoms. Arch Neurol Psychiatry 1945; 54:348-360.

McAlpine D. Symptoms and signs. In: McAlpine D, Lumsden CE, Acheson ED, eds. Multiple Sclerosis: A Reappraisal. Baltimore: Williams and Wilkins, 1972:132-196. Muller R. Studies on disseminated sclerosis with special reference to symptomatology, course and prognosis. Acta Med Scand Suppl 1949; 222:1-214.

Adams DK, Sutherland JM. Early clinical manifestations of disseminated sclerosis. Br Med J 1950; 2:431-436.

Kurtzke JF. Clinical manifestations of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Multiple Sclerosis and Other Demylinating Diseases. Vol. 9. Amsterdam: North Holland, 1970:161-216.

Miller AE, Lublin FD, Coyle PK. Multiple Sclerois in Clinical Practice. London: Martin Dunitz, 2003: 103-129.

Matthews WP. Symptoms and signs. In: Matthews WB, Acheson ED, Bachelor JR, Weller RO, eds. McAlpine's Multiple Sclerosis. Edinburgh: Churchill Livingstone, 1985:98-116.

Clifford DB, Trotter JL. Pain in multiple sclerosis. Arch Neurol 1984; 41:1270-1272. Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology 1988; 38:1830-1834.

44. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Multiple Sclerosis and Other Demyelinating Diseases. Vol. 9. Amsterdam: North Holland, 1970:217-309.

45. Cowan J, Ormerodl IE, Rudge P. Hemiparetic multiple sclerosis. J Neurol Neurosurg Psychiatry 1990; 53:675-680.

46. Larson EB, Burnison DS, Brown WS. Callosal function in multiple sclerosis: bimanual motor conduction. Cortex 2002; 38:201-214.

47. Rae-Grant AD, Eckert NJ, Bartz S, Reed JF. Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity. Mult Scler 1999; 5:179-183.

48. Mathews WB. Tonic seizures in disseminated sclerosis. Brain 1958; 81:193-206.

49. Lhermitte J, Bollak P, Nichas M. Les douleurs a type de decharge electrique consecutives a la fexion cephalique dans la sclerose en plaques. Rev Neurol 1924; 42:56-62.

50. Kanchandani R, Howe JG. Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature. J Neurol Neurosurg Psychiatry 1982; 45:308-312.

51. Ramirez-Lassepas M, Tullock JW, Quinones MR, Snyder BJ. Acute radicular pain as a presenting symptom in multiple sclerosis. Arch Neurol 1992; 49:255-258.

52. Cosman F, Nieves J, Komar L, et al. Fracture history and bone loss in patients with multiple sclerosis. Neurology 1998; 51:1161-1165.

53. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994; 44:1687-1692.

54. Schwid SR, Goodman AD, Puzas JE, McDermott MP, Mattson DH. Sporadic corti-costeroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 1996; 53:753-757.

55. Haas DC, Kent PF, Freidman DL. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache 1993; 33:452-455.

56. Galer BS, Lipton RB, Weinstein S, Bello L, Solomon S. Apoplectic headache and oculomotor palsy: an unusual presentation of multiple sclerosis. Neurology 1990; 40: 1465-1466.

57. Wilson SAK. Case of disseminated sclerosis with weakness of each internal rectus and nystagmus on lateral deviation limited to the outer eye. Brain 1906; 29:298.

58. Bender MB, Weinstein EA. Dissociated monocular nystagmus with paresis of horizontal ocular movements. Arch Ophthalmol 1939; 21:266-272.

59. Cogan DG. Internuclear ophthahnopegia, typical and atypical. Arch Ophthalmol 1970; 84:583-589.

60. Muri R, Meienberg O. The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis. Arch Neurol 1985; 42:851-855.

61. Joseph R, Pullicino P, Goldberg CDS, Rose FC. Bilateral pontine gaze palsy. Arch Neurol 1985; 42:93-94.

62. Slyman JF, Kline LB. Dorsal midbrain syndrome in multiple sclerosis. Neurology 1981; 31:196-198.

63. Quint DJ, Cornblath WT, Trobe JD. Multiple sclerosis presenting as Parinaud syndrome. Am J Neuroradiol 1993; 14:1200-1202.

64. Fisher CM. Some neuro-ophthalmological observations. J Neurol Neurosurg Psychiatry 1967; 30:383-392.

65. Wall M, Wray SH. The one-and-a-half syndrome—a unilateral disorder of the pontine tegmentum: a study of 20 cases and review of the literature. Neurology 1983; 33: 971-980.

66. Keane JR. Alternating skew deviation: 47 patients. Neurology 1985; 35:725-728.

67. Frohman EM, Frohman TC, Fleckenstein J, Racke MK, Hawker K, Kramer PD. Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms. J Neurol Neurosurg Psychiatry 2001; 70:688-692.

68. Barton JJ, Cox TA, Digre KB. Acquired convergence-evoked pendular nystagmus in multiple sclerosis. J Neuroophthalmol 1999; 19:34-38.

69. Reche Sainz JA, Espinet Badia R, Puig Ganau T. Divergence insufficiency and demye-linating disorder. Eur J Opthalmol 2002; 12:238-240.

Dailey FL, Brown JR, Goldstein FJ. Dysarthria in multiple sclerosis. Speech Hear Res 1972; 15:229-245.

Miller AE. Cessation of stuttering with progressive multiple sclerosis. Neurology 1985; 35:1341-1343.

Ivers RR, Goldstein NP. Multiple sclerosis: a current appraisal of symptoms and signs. Mayo Clin Proc 1963; 338:457-466.

Jankovic J, Patel SC. Blepharospasm associated with brainstem lesions. Neurology 1983; 33:1237-1240.

Andermann F, Cosgrove JBR, Lloyd-Smith DL, Gloor P, McNaughton FL. Facial myokymia in multiple sclerosis. Brain 1961; 84:31-44.

Matthews WB. Facial myokymia. J Neurol Neurosurg Psychiatry 1966; 29:35-39. Daugherty WT, Lederman RJ, Nodar RH, Conomy JP. Hearing loss in multiple sclerosis. Arch Neurol 1983; 40:33-35.

Drulovic B, Ribaric-Jankes K, Kostic V, Sternic N. Sudden hearing loss as the initial monosymptom of multiple sclerosis. Neurology 1993; 43:2703-2705.

Sasaki O, Ootsuka K, Taguchi K, Kikukawa M. Multiple sclerosis presented acute hearing loss and vertigo. J Otorhinolaryngol Relat Spec 1994; 56:55-59.

Tabira T, Tsuji S, Nagashima T, Nakajima T, Kuroiwa Y. Cortical deafness in multiple sclerosis. J Neurol Neurosurg Psychiatry 1981; 44:433-436.

Weber H, Pfadenhauer K, Stohr M, Rosler A. Central hyperacusis with phonophobia in multiple sclerosis. Mult Scler 2002; 8:505-509.

Cure JK, Cromwell D, Case JL, Johnson GD, Musiek FE. Auditory dysfunction caused by multiple sclerosis: detection with MR imaging. Am J Neuroradiol 1990; 11:817-820. Birkhead R, Friedman HJ. Hiccups and vomiting as initial manifestations of multiple sclerosis. J Neurol Neurosurg Psychiatry 1987; 50:232-233.

McFarlin DA, Susac JO. Hoquet diabolique: intractable hiccups as a manifestation of multiple sclerosis. Neurology 1979; 29:797-801.

Boomer JA, Siatkowski RM. Optic neuritis in adults and children. Semin Ophthalmol 2003; 18:174-180.

Slamovits TL, Rosen CE, Cheng KP, Striph GG. Visual recovery in patients with optic neuritis and visual loss to no light perception. Am J Ophthalmol 1991; 111:209-214. Beck RW, Cleary PA, Backlund JC. The course of visual recovery after optic neuritis. Experience of the optic neuritis treatment trial. Ophthalmology 1994; 101:1771-1778. Steinmetz R, Kearns TP. H-R-R pseudoisochromatic plates as a diagnostic aid in retrobulbar neuritis of multiple sclerosis. Am J Ophthalmol 1956; 41:833-837. Stanley JA, Baise G. The swinging flashlight test to detect minimal optic neuropathy. Arch Ophthalmol 1968; 80:769-771.

Balcer LJ, Baier ML, Petak VS, et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler 2000; 6:163-171. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet 1972; 1:982-985.

Lowitzsch K. Pattern-evoked visual potentials in 251 multiple sclerosis patients in relation to ophthalmological findings and diagnostic classification. In: Bauer HJ, Poser S, Ritter G, eds. Progress in Multiple Sclerosis Research. Berlin: Springer Verlag, 1980:571-577.

Sanchez-Dalmau B, Goni FJ, Gurro M, Ruig C, Duch-Bordas F. Bilateral homon-ymous visual field defects as initial manifestation of multiple sclerosis. Br J Ophthalmol 1991; 75:185-187.

Slavin ML. Acute homonymous field loss: really a diagnostic dilemma. Surv Ophthal-mol 1990; 34:399-407.

Frederiksen JL, Larsson HB, Nordenho AM, Seedorff HH. Plaques causing hemianopsia or quadrantanopsia in multiple sclerosis identified by MRI and VEP. Acta Ophthalmol 1991:169-177.

95. Wender M, Szmeja Z. Examination of vestibular system function, taste and olfactory systems in patients with disseminated sclerosis. Neurol Neurochir Pol 1971; 21:179-184.

96. Matthews WB. Symptoms and signs. In: Matthews WB, Acheson ED, Batchelor JR, Weller RO, eds. McAlpine's Multiple Sclerosis. Edinburgh: Churchill Livingstone, 1985:119-145.

97. Doty RL, Li C, Mannon LJ, Youssam DM. Olfactory dysfunction in multiple sclerosis. N Engl J Med 1997; 336:1918-1919.

98. Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. J Neurol Sci 1999; 168:127-130.

99. Zorzon M, Ukmar M, Bragadin LM, et al. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Mult Scler 2000; 6:386-390.

100. Hawkes CM, Shephard BC, Kobal G. Assessment of olfaction in multiple sclerosis: evidence of dysfunction by olfactory evoked response and identification tests. J Neurol Neurosurg Psychiatry 1997; 63:145-151.

101. Cohen L. Disturbance of taste as a symptom of multiple sclerosis. Br J Oral Surg 1965; 2:184-185.

102. Pascual-Leone A, Altafullah I, Dhura A. Hemiageusia: an unusual presentation of multiple sclerosis. J Neurol Neurosurg Psychiatry 1991; 54:657.

103. Harris W. Rare forms of paroxysmal trigeminal neuralgia, and their relation to disseminated sclerosis. Br Med J 1950; 2:1015.

104. Rao SM, Hammeke TA, McQuillen MP, Khatri BO, Lloyd D. Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol 1984; 41:625-631.

105. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003; 16:283-288.

106. Amato MP, Ponziani G, Siracusa G, et al. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001; 58:1602-1606.

107. Peyser JM, Edward KR, Poser CM, Filskov SB. Cognitive function in patients with multiple sclerosis. Arch Neurol 1980; 37:577-579.

108. Beatty WW. Cognitive and emotional disturbances in multiple sclerosis. Neurologic Clin 1993; 11:189-204.

109. Hamalainen P, Ruutiainen J. Cognitive decline in multiple sclerosis. Internat Mult Scler J 1999; 6:51-57.

110. Kotterba S, Orth M, Eren E, Fangerau T, Sindern E. Assessment of driving performance in patients with relapsing-remitting multiple sclerosis by a driving simulator. Eur Neurol 2003; 50:160-164.

111. Schultheis MT, Garay E, Deluca J. The influence of cognitive impairment on driving performance in multiple sclerosis. Neurology 2001; 56:1089-1094.

112. Schultheis MT, Garay E, Millis SR, Deluca J. Motor vehicle crashes and violations among drivers with multiple sclerosis. Arch Phys Med Rehabil 2002; 83:l175-1178.

113. Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry 2003; 74:872-877.

114. Huber SJ, Paulson GW, Shuttleworth EC, et al. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol 1987; 44:732-736.

115. Franklin GM, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology 1988; 38:1826-1829.

116. Olmos-Lau N, Ginsberg MD, Geller JB. Aphasia in multiple sclerosis. Neurology 1977; 27:623-626.

117. Friedman JH, Brem H, Mayeux R. Global aphasia in multiple sclerosis. Ann Neurol 1983; 13:222-223.

118. Achiron A, Ziv I, Djaldetti R, Goldberg H, Kuritzky A, Melamed E. Aphasia in multiple sclerosis: clinical and radiologic correlations. Neurology 1992; 42:2195-2197.

Graff-Radford NR, Rizzo M. Neglect in a patient with multiple sclerosis. Eur Neurol 1987; 26:100-103.

Cottrell SS, Wilson SAK. The affective symptomatology of disseminated sclerosis. J Neurol Psychopathol 1926; 7:1-30.

Whitlock FA, Siskind MM. Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43:861-865.

Baretz RM, Stephenson GR. Emotional responses to multiple sclerosis. Psychosomatics 1981; 22:117-127.

Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2003; 49: 157-163.

Sadovnik AD, Eisen RN, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41:1193-1196.

Feinstein A. An examination of suicidal intent in patients with, multiple sclerosis. Neurology 2002; 59:674-678.

Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 1985; 312:1480-1482.

Honer WG, Hurwitz T, Li DKB, et al. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 1987; 44:187-190.

Feinstein A, duBoulay G, Ron MA. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry 1992; 161:680-685.

Murray TJ. Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci

1985; 12:251-254.

Freal JE, Kraft GH, Coryell SK. Symptomatic fatigue in multiple sclerosis. Arch Physical Med Rehabil 1984; 65:135-138.

Schwid SR, Covington M, Segal BM, Goodman AD. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 2002; 39:211-224. Krupp L, La Rocca NG, Muir-Nash J, Steinberg AD. Fatigue severity scale. Neurology 1988; 38(l):99-100.

Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbances, depression, and lesion site in patients with multiple sclerosis. Arch neurol 1992; 49: 641-643.

Miller H, Simpson CA, Yeates WK. Bladder dysfunction in multiple sclerosis. Br Med J 1965; 1:1265-1269.

DasGupta R, Fowler CJ. Bladder, bowel, and sexual dysfunction in multiple sclerosis. Drugs 2003; 63:153-166.

Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 245-250.

Strauss BS, Blaufox MD. Estimation of residual urine and urine flow rate without urethral catheterizaton. J Nucl Med 1970; 11:81-85.

Blaivas JG, Barbalias GA. Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition. J Urol 1984; 131:91-94. Hinds JP, Eidelman BH, Wald A. Prevalence of bowel dysfunction in multiple sclerosis: a population survey. Gastroenterology 1990; 98:1538-1542.

Sullivan SN, Ebers GC. Gastrointestinal dysfunction in multiple sclerosis [letter]. Gastroenterology 1982; 84:1640.

Fowler CJ, Henry MM. Gastrointestinal dysfunction in multiple sclerosis. Internat Mult Scler J 1999; 6:59-61.

Chia YW, Fowler C, Kamm M, et al. Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol 1995; 242:105-108. Nordenbo A, Andersen J, Andersen J. Disturbances of ano-rectal function in multiple sclerosis. J Neurol 1996; 243:445-451.

Zorzon M, Zivadinov R, Bosco A, et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999; 5:418-427.

145. Lundberg PO. Sexual dysfunction in female patients with multiple sclerosis. Int Rehabil Med 1981; 3:32-34.

146. Gondim FA, Thomas FP. Episodic hyperlibidinism in multiple sclerosis. Mult Scler 2001; 7:67-70.

147. Nyquist PA, Cascino GD, McClelland RL, et al. Incidence of seizures in patients with multiple sclerosis: a population-based study. Mayo Clin Proc 2002; 77:910-912.

148. Gambardella A, Valentino P, Labate A, et al. Temporal lobe epilepsy as a unique manifestation of multiple sclerosis. Can J Neurol Sci 2003; 30:228-232.

149. Joynt RJ, Green D. Tonic seizures as a manifestation of multiple sclerosis. Arch Neurol 1962; 6:293-299.

150. Twomey JA, Espir MLE. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43:296-304.

151. Heath PD, Nightingale S. Clusters of tonic spasms as an initial manifestation of multiple sclerosis. Ann Neurol 1986; 12:494-495.

152. Berger JR, Sheremata WA, Melamed E. Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol 1984; 41:747-750.

153. Osterman PO, Westerberg CE. Paroxysmal attacks in multiple sclerosis. Brain 1975; 98:189-202.

154. Maimone D, Reder AT, Finocchiaro F, Recuper E. Internal capsule plaque and tonic spasms in multiple sclerosis. Arch Neurol 1991; 48:427-429.

155. Burguera JA, Catala J, Casanova B. Thalamic demyelination and paroxysmal dystonia in multiple sclerosis. Mov Disord 1991; 6:379-381.

156. Rose MR, Ball JA, Thompson PD. Magnetic resonance imaging in tonic spasms of multiple sclerosis. J Neurol 1993; 241:115-117.

157. Uncini A, DiMuzio A, Thomas A, Lugaresi A, Gambi D. Hand dystonia secondary to cervical demyelinating lesion. Acta Neurol Scand 1994; 90:51-55.

158. Espir MLE, Watkins MS, Smith HV. Paroxysmal dysarthria and other transient neurological disturbances in disseminated sclerosis. J Neurol Neurosurg Psychiatry 1966; 29:323-330.

159. Anderman F, Cosgrove JBR, Lloyd-Smith D, Walters AM. Paroxysmal dysarthria and ataxia in multiple sclerosis. Neurology 1959; 9:211-215.

160. Yamamoto M, Yabuki SK, Hayabara T, Otsuki S. Paroxysmal itching in multiple sclerosis: a report of three cases. J Neurol Neurosurg Psychiatry 1981; 44:19-22.

161. Telischi FF, Grobman LR, Sheremata WA, Apple M, Ayyar R. Hemifacial spasm occurring in multiple sclerosis. Arch Otolaryngol Head Neck Surg 1991; 117:554-556.

162. Brisman R. Trigeminal neuralgia in multiple sclerosis. Arch Neurol 1987; 44:379-381.

163. Rozza L, Bortolotti P, Sica A, Wereonig S, Orrico D. Kinesigenic dystonia as the first manifestation of multiple sclerosis with cervical and brainstem lesions. Eur Neurol 1993; 34:331-332.

164. Roos RA, Wintzen AR, Vielvoye G, Polder TW. Paroxysmal kinesigenic choreoatheto-sis as presenting symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1991; 54:657-658.

165. Kapoor R, Brown P, Thompson PD, Miller DH. Propriospinal myoclonus in multiple sclerosis. J Neurol Neurosurg Psychiatry 1992; 55:1086-1088.

166. D'Costa DF, Vania AK, Millac PA. Multiple sclerosis associated with trismus. Postgrad Med J 1990; 66:853-854.

167. Scolding NJ, Lees AJ. Micrographia associated with a parietal lobe lesion in multiple sclerosis. J Neurol Neurosurg Psychiatry 1994; 57:739-741.

168. Noronha MJ, Vas CJ, Aziz H. Autonomic dysfunction (sweating responses) in multiple sclerosis. J Neurol Neurosurg Psychiatry 1968; 31:19-22.

169a. Cartlidge NEF. Autonomic function in multiple sclerosis. Brain 1972; 95:661-664.

169b. Newsom-Davis J. Autonomous breathing. Arch Neurol 1974; 30:480-483.

170. Kuwahira I, Kondo T, Ohta Y, Yamabayashi H. Acute respiratory failure in multiple sclerosis. Chest 1990; 97:246-248.

Aisen M, Arlt G, Foster S. Diaphragmatic paralysis without bulbar or limb paralysis in multiple sclerosis. Chest 1990:499-501.

Cooper CA, Trend PS, Wiles CM. Severe diaphragmatic weakness and multiple sclerosis. Thorax 1985; 40:633-634.

White KD, Scoones DJ, Newman PK. Hypothermia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 61:369-375.

Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46:907-911.

Millar JHD, Allison RS, Cheeseman EA, Merrett JD. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959; 82:417-426.

Gudmundsson KR. Clinical studies of multiple sclerosis in Iceland. Acta Neurol Scand Suppl 1971; 48:1-78.

Leibowitz U, Alter M. Multiple Sclerosis: Clues to Its Cause. Amsterdam: North Holland, 1973.

Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980; 103:281-300. Alexander L, Berkeley AW, Alexander AM. Prognosis and treatment of multiple sclerosis: quantitative nosometric study. JAMA 1958; 166:1943-1949.

Interferon beta-lb Multiple Sclerosis Study Group. Interferon beta lb is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993:43:655-661. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-la for disease progression in relapsing multiple sclerosis. Ann Neurol 1996; 39:285-294. Johnson KP, Brooks BR, Cohen JA, et al. Copolymer 1 reduces the relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of phase III multicenter, double-bind, placebo-controlled trial. Neurology 1995; 445:1268-1276. Broman T, Anderson O, Bergmann L. Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenberg. Acta Neurol Scand 1981; 63:6-33. Lhermitte F, Marteau RK, Gazengel J, Dordain G, Deloche G. The frequency of relapse in multiple sclerosis: a study based on 245 cases. J Neurol 1973; 205:47-59. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance lesions. Ann Neurol 1993: 33:480-489.

Weinshenker BG, Bass B, Rice GPB, et al. The natural history of multiple sclerosis: a geographically-based study. 1. Clinical course and disability. Brain 1989; 112:133-146. Sibley WA. Therapeutic Claims in Multiple Sclerosis. 3rd ed. New York: Demos, 1988:1-15.

Miller A, Drexler E, Keilson M, et al. Spontaneous stabilization in patients with chronic progressive MS. Neurology 1988: 38(suppl 1):194.

Wynn DR, Rodriquez M, O'Fallon WM, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990; 40:780-786. Kurtzke JF, Beebe GW, Nagler B, Nefzger MD, Auth TL, Kurland LT. Studies on the natural history of multiple sclerosis. V. Long-term survival in young men. Arch Neurol 1970; 22:215-225.

Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127:844-850. Bauer HJ, Firnhaber W. Zur leistungsprofose multiple sklerose-kranker. Dtsch Med Wochenschr 1963; 88:1357-1364.

Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20-year-old population-based follow-up study. Ann Neurol 2004; 556: 303-306.

Kraft GH, Freal JE, Coryell JK, Hanana CL, Chitnis N. Multiple sclerosis: early prognostic guideline. Arch Physical Med Rehabil 1981; 62:54-58.

195. Bonduelle M. Les formes benignes de la sclerose en plaques. Presse Med 1967; 75: 2023-2026.

196. Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL. Studies on the natural history of multiple sclerosis. VIII. Early prognostic features of the later course of the illness. J Chronic Dis 1977; 30:819-830.

197. Sibley WA, Bamford CR, Clark K. Clinical viral infections in multiple sclerosis. Lancet 1985; 1:313-315.

198. Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 1994; 36:S25-S28.

199. McAlpine D, Compston ND. Some aspects of the natural history of disseminated sclerosis. Q J Med 1952; 21:135-167.

200. Banford CR, Sibley WA, Thies C, Laguna JF, Smith MS, Clark K. Trauma as an etiologic and aggravating factor in multiple sclerosis. Neurology 1981; 31:1229-1234.

201. Ridley A, Schapira K. Influence of surgical procedures on the course of multiple sclerosis. Neurology 1961; 11:81-82.

202. Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999; 52:1737-1745.

203. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. Br Med J 2004; 328:731.

204. Braceland FJ, Griffin ME. The mental changes associated with multiple sclerosis (an interim report). Res Public Assoc Res Nerv Ment Dis 1950; 28:450-455.

205. Pratt RTC. An investigation of the psychiatric aspects of disseminated sclerosis. J Neurol Neurosurg Psychiatry 1951; 14:326-332.

206. Alter M, Antonovsky AK, Leibowitz U. Epidemiology of multiple sclerosis in Israel. In: Alter M, Kurtzke J, eds. The Epidemiology of Multiple Sclerosis. Springfield, IL: Charles C. Thomas, 1968:83-109.

207. Franklin GM, Nelson LM, Heaton RK, Burks JS, Thompson DS. Stress and its relationship to acute exacerbations in multiple sclerosis. J Neurol Rehabil 1988; 2:7-11.

208. Nispeanu P, Korczyn A. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993; 43:1311-1312.

209. Nelson DA, McDowell F. The effects of induced hyperthermia on patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1959; 22:113-116.

210. Uhthoff W. Untersuchungen uber die bei der multiplen Herdsklerose vorkommenden Augenstorungen. Arch Psychiatr Nevenkr 1889; 20:55.

211. Goldstein JE, Cogan DG. Exercise and the optic neuropathy of multiple sclerosis. Arch Ophthalmol 1964; 72:168-170.

212. Nelson DA, Jeffreys WH, McDowell F. Effects of induced hyperthermia on some neurological diseases. Arch Neurol Psychiatry 1958; 79:31-39.

213. Berger JR, Sheremata WA. Persistent neurological deficits precipitated by the hot bath test in multiple sclerosis. JAMA 1983; 249:1751-1753.

214. Rasminsky M. The effects of temperature on conduction in demyelinated single nerve fibers. Arch Neurol 1973; 28:287-292.

215. Korn-Lubetzki I, Kahana E, Cooper G, Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 1984; 15:229-231.

216. Thomason DS, Nelson LM, Burns A, Burks JS, Franklin GM. The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 1986; 36:1097-1099.

217. Frith JA, McLeod JG. Pregancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 1988; 51:495-498.

218. Leibowitz U, Antonovsky A, Kats R, Alter M. Does pregnancy increase the risk of multiple sclerosis? J Neurol Neurosurg Psychiatry 1967; 30:354-357.

219. Birk K, Rudick R. Pregnancy and multiple sclerosis. Arch Neurol 1986; 43:719-725.

220. Birk K, Smeltzer SK, Ford C, Miller R, Rudick R. The effect of pregnancy in multiple sclerosis. Neurology 1988; 38(suppl 1):237.

221. Sadovnick AD, Eisen K, Hashimoto SA, et al. Pregnancy and multiple sclerosis. A prospective study. Arch Neurol 1994; 51:1120-1124.

222. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. The Pregnancy in Multiple Sclerosis Group Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339:285-291.

223. Runmarker B, Anderson O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118:253-261.

224. Berdru P, Theys P, D'Hooghe MB, et al. Pregnancy in multiple sclerosis: the influence on long-term disability. Clin Neurol Neurosurg 1994; 96:38-41.

Hearing Aids Inside Out

Hearing Aids Inside Out

Have you recently experienced hearing loss? Most probably you need hearing aids, but don't know much about them. To learn everything you need to know about hearing aids, read the eBook, Hearing Aids Inside Out. The book comprises 113 pages of excellent content utterly free of technical jargon, written in simple language, and in a flowing style that can easily be read and understood by all.

Get My Free Ebook

Post a comment